Home | Structured Search | Drug Resource
Find: within
Obesity > Diagnosis Author: George A. Bray, MD
Editorial changes - 2009-11-18
Author information and module status
Prevention
Screening
Diagnosis
Consultation for Diagnosis
Hospitalization
Non-drug Therapy
Drug Therapy
Patient Education
Consultation for Management
Follow-up

Tables
Figures
References
Glossary
What's New
Patient Information
Additional Resources
Tools

Quality Measures Quality Measures

Rationale:

  • Laboratory testing can confirm clinical impressions and provide information not detectable on physical examination.

Evidence:

  • Casual glucose >200 mg/dL with symptoms of diabetes constitute a criterion for diagnosis (328).
  • Fasting glucose >126 mg/dL on two occasions or 2-hour glucose >200 mg/dL on two occasions during an oral GTT with 75 g of glucose is diagnostic of diabetes (328).
  • Impaired fasting glucose is defined as a fasting glucose between 100 and 126 mg/dL (328).
  • Impaired glucose tolerance is defined by a glucose between 140 and <200 mg/dL at 2 hours during an oral GTT (328).
  • Low HDL cholesterol and high triglycerides are components of the metabolic syndrome (236).
  • Ultrasound of the liver has a good correlation with hepatic fat (329).
  • Metabolic syndrome can be diagnosed by several criteria. The metabolic syndrome and its individual components predicted the incidence of cardiovascular disease and stroke equally well (330).

Comments:

  • If a child's weight is above the 99th percentile for height and rising further above this upper bound, genotyping for genetic disorders associated with obesity may be considered. For example, children with very high BMI may have genetic defects in melanocortin receptor or other genes (62).

FAQs
George A. Bray, MD, is a speaker for Eli Lilly, Amylin Corp., and Merck & Co., received grants from Merck & Co., and Takeda Pharmaceuticals; and has consulted for Sanofi-Aventis, Merck, and Amylin.
Steven E. Weinberger, MD, FACP, Acting Editor, PIER, has stock holdings in Glaxosmithkline and Abbott.


The information included herein should never be used as a substitute for clinical judgment and does not represent an official position of ACP. Because all PIER modules are updated regularly, printed web pages or PDFs may rapidly become obsolete. Therefore, PIER users should compare the date of the last update on the website with any printout to ensure that the information being referred to is the most current available.
PIER is copyrighted (c) 2009 by the American College of Physicians,
190 N. Independence Mall West, Philadelphia, PA 19106-1572, USA.